Multiple Assemblies exist for SMTL entry 3g5n
Triple ligand occupancy crystal structure of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole; X-RAY DIFFRACTION 2.50 Å

	SMTL ID 3g5n.1 Ligands PROTOPORPHYRIN IX CONTAINING FE; 1-(biphenyl-4-ylmethyl)-1H-imidazole; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE Polypeptides Cytochrome P450 2B4 Oligo-state homo-tetramer
	SMTL ID 3g5n.2 Ligands PROTOPORPHYRIN IX CONTAINING FE; 1-(biphenyl-4-ylmethyl)-1H-imidazole; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE Polypeptides Cytochrome P450 2B4 Oligo-state monomer
	SMTL ID 3g5n.3 Ligands 1-(biphenyl-4-ylmethyl)-1H-imidazole; PROTOPORPHYRIN IX CONTAINING FE; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE Polypeptides Cytochrome P450 2B4 Oligo-state monomer
	SMTL ID 3g5n.4 Ligands PROTOPORPHYRIN IX CONTAINING FE; 1-(biphenyl-4-ylmethyl)-1H-imidazole; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE Polypeptides Cytochrome P450 2B4 Oligo-state monomer
	SMTL ID 3g5n.5 Ligands 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE; PROTOPORPHYRIN IX CONTAINING FE; 1-(biphenyl-4-ylmethyl)-1H-imidazole Polypeptides Cytochrome P450 2B4 Oligo-state monomer